Back to results
US 2019/0030156 A1Published application
Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine
AssigneeTechnoVax, Inc.
InventorsJose M. GALARZA, Velasco CIMICA, Hélène BOIGARD
Life of this patent
Estimating the term…
Abstract
Described herein are virus-like particles (VLPs) that display on their surfaces antigenic paramyxovirus (e.g., RSV and/or MPV) proteins. Also described are methods of making and using these VLPs.
Claims23
1-21. (canceled)
A virus-like particle (VLP) comprising
- at least one metapneumovirus (MPV) structural protein;
- and
- at least one surface MPV or respiratory syncytial virus (RSV) protein.
Dependencies are inferred from the claim text.